Gustave Roussy company information, Employees & Contact Information

Gustave Roussy at the ESMO 2025 Congress Gustave Roussy

Gustave Roussy Unveils an Inspiring New Campaign Gustave Roussy

Age-related genetic changes in the blood associated with poor cancer prognosis Gustave Roussy

Applications open for the 2026 Gustave Roussy Prize Gustave Roussy

Gustave Roussy Remains the No. 1 Cancer Centre in France and Europe Gustave Roussy

Opening of the First Gustave Roussy-Branded Facility in Egypt Gustave Roussy

Gustave Roussy Prize: €200,000 Award for Cancer Researcher Applications Open Oncodaily

A Potential New Cell Therapy for Pediatric Neuroblastoma – Gustave Roussy Oncodaily

Gustave Roussy at the ASCO 2025 Congress Gustave Roussy

Elsa Bernard Awarded Prestigious ERC Starting Grant Gustave Roussy

Professor Aurélien Marabelle joins the Board of Directors of the Society for Immunotherapy of Cancer (SITC) Gustave Roussy

Three Inaugural Chairs of Excellence from the Gustave Roussy Foundation for Cancer Research Gustave Roussy

Biography Cécile Badoual Gustave Roussy

Gustave Roussy is exporting its model of excellence internationally with a first branded oncology center in Egypt Gustave Roussy

Research focus: Three Other Breakthroughs to Watch Gustave Roussy

Gustave Roussy at the AACR 2025 Congress Gustave Roussy

OASIS, a new European research programme to optimise antibody-drug conjugates Gustave Roussy

Gustave Roussy Authorised to Conduct Phase I Clinical Trials in Nuclear Medicine Gustave Roussy

Path-For-Young, an international project to personalise care for young women with breast cancer Gustave Roussy

The President of the French Republic lays the foundation stone for Gustave Roussy’s new research building Gustave Roussy

The inaugural edition of the Gustave Roussy Prize awarded to Professor Charles Swanton Gustave Roussy

Take part in the 4th edition of the Transatlantic Exchanges dedicated to radioligand therapies Gustave Roussy

Olivier Rousteing and Gustave Roussy commit to cure childhood cancer in the 21st century 💛 lepetitprince.com

A New Award for Innovation in Oncology Gustave Roussy

16 Researchers from Gustave Roussy Among the Most Influential in the World Gustave Roussy

Dr. Suzette Delaloge Receives the Grand Prix de la Recherche Ruban Rose Gustave Roussy

Gustave Roussy at ESMO Congress 2024 Gustave Roussy

Gustave Roussy, the first cancer research and treatment center in France and Europe, maintains its position in the top 5 hospitals for oncology globally Gustave Roussy

Gustave Roussy at ASCO 2023 Gustave Roussy

CARE1: A European Study on First-Line Treatment of Metastatic Kidney Cancer Gustave Roussy

Emerging Biotherapeutics Program Gustave Roussy

Research agreement between Gustave Roussy and Amgen to predict the effectiveness of antibodies drug conjugates Gustave Roussy

Gustave Roussy in the world's Top 5 cancer hospitals Gustave Roussy

Gustave Roussy in the world's TOP 3 cancer hospitals Gustave Roussy

Gustave Roussy at the ASCO 2024 conference: a particularly rich edition Gustave Roussy

Working with cancer: the film Monday pleads for benevolence Gustave Roussy

Allo-CAR-T cells: one step closer to standardized and accessible cell therapies Institut Curie

Gustave Roussy’s General Director, an ambassador of French excellence in the “MAKE IT ICONIC. Choose France” campaign Gustave Roussy

Gustave Roussy and LXRepair announce a partnership for personalized radiotherapy of cancer Gustave Roussy

Gustave Roussy among the top 5 best cancer hospitals in the world Gustave Roussy

Research in Immunotherapy Gustave Roussy

Sanofi and Gustave Roussy are strengthening their strategic oncology research collaboration Gustave Roussy

Emerging Clonal Interception Program Gustave Roussy

Servier and Gustave Roussy sign a framework agreement for a strategic collaboration in oncology and immuno-oncology Gustave Roussy

Dana-Farber Cancer Institute, Gustave Roussy, and L’Institut Servier sign an oncology cooperation agreement Gustave Roussy

France is set to become a global leader in using AI to diagnose and treat diseases through €33 million Owkin-led AI project Gustave Roussy

RHU REMISSION : Characterizing the biological specificities of patients and their tumors to develop new immunotherapies Gustave Roussy

Bob Pinedo Cancer Care Award 2022 for Laurence Zitvogel Gustave Roussy

Emerging Epigenetics Program Gustave Roussy

The FOSTER-CabOs project has received funding for a clinical trial concerning osteosarcoma Gustave Roussy

Professor Jean-Charles Soria appointed General Director of Gustave Roussy Gustave Roussy

Strategic Plan 2030 : Smart Hospital Gustave Roussy

Newsweek magazine places Gustave Roussy among the top 5 best cancer hospitals in the world Gustave Roussy

Gustave Roussy at the ESMO 2018 Congress Gustave Roussy

ORPHELIA Pharma and Gustave Roussy announce the publication in Pharmaceuticals of the scientific work related to the development of the first temozolomide oral suspension for children Gustave Roussy

Professor Fabrice Barlesi is appointed General Director of Gustave Roussy Gustave Roussy

Creation of a patient-centered biocluster in oncology Gustave Roussy

Strategic Plan 2030 : interview Gustave Roussy

PortrAIt: Artificial intelligence for cancer diagnosis and therapy Gustave Roussy

Professor Fabrice Barlesi becomes Gustave Roussy Medical Director Gustave Roussy

Strategic Plan 2030 - Towards ultra-individualisation and anticipation in oncology Gustave Roussy

An innovative technique to prevent and reduce some side effects of cancer treatment Gustave Roussy

Strategic Plan 2030 : prevent and treat Gustave Roussy

ONCOBIOME, 1st consortium about microbiome & cancer, led by Gustave Roussy Gustave Roussy

The Crescendo Programme Gustave Roussy

ORPHELIA Pharma and Gustave Roussy announce issuance of European Patent covering Kimozo Gustave Roussy

Pr Antoine Italiano (institut Bergonié) joins Gustave Roussy to head the precision oncology program Gustave Roussy

Death of Professor Thomas Tursz Gustave Roussy

Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia JCI.org

Precision drug to stimulate immune system against some cancers Gustave Roussy

Apply for the "Course of Excellence in Oncology - Fondation Philanthropia" Gustave Roussy

Gustave Roussy, leading centre of immunotherapy in Europe Gustave Roussy

Gustave Roussy at the ASCO Annual Meeting 2018 Gustave Roussy

Gustave Roussy to host its first ESMO Fellowship Awardee Gustave Roussy

Gustave Roussy joins the Worldwide Innovative Network (WIN) in personalized cancer medicine consortium- WIN Consortium Gustave Roussy

Early clinical trials (phase I) Gustave Roussy

New Integrated Research Center of Excellence in Pediatric Oncology to fight against cancers in children and adolescents Institut Curie

Gustave Roussy and THERYQ: France welcomes the first FLASH radiotherapy machine to treat patients PR Newswire Canada

National Day of Screening for Skin Cancer Salle de presse de l'Inserm